Protara Therapeutics Inc. (TARA)
3.44
-0.30 (-8.02%)
At close: Mar 03, 2025, 3:59 PM
3.23
-6.24%
After-hours: Mar 03, 2025, 07:17 PM EST
Protara Therapeutics Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -40.42M | -65.95M | -47.25M | -33.98M | -14.99M | -20.73M | -29.96M | -28.53M | -21.38M | -3.34M | -7.91M | -7.97M |
| Depreciation & Amortization | 341K | 248K | 117K | 196K | 279K | 115K | 148K | 123K | 57K | 30K | 27K | 57K |
| Stock-Based Compensation | 6.09M | 6.69M | 10.36M | 9.75M | 943K | 3.43M | 925.71 | 3.34M | 2.16M | 459K | n/a | n/a |
| Other Working Capital | -4.99M | -92K | 494K | 431K | 625K | 190K | 4.46M | 1.32M | 359K | -846K | 183K | 320K |
| Other Non-Cash Items | 569K | 32.02M | 1.74M | 9.94M | -4K | -76K | 3.39M | 3.69M | 3.57M | -7.25M | 821K | 243K |
| Deferred Income Tax | n/a | n/a | n/a | -9.94M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -4.14M | 539K | 534K | 629K | -1.87M | -5.97M | 4.41M | 1.29M | 327K | 109K | 361K | -564K |
| Operating Cash Flow | -37.56M | -26.46M | -34.5M | -23.41M | -15.65M | -23.23M | -22.35M | -23.69M | -17.57M | -9.99M | -6.7M | -8.23M |
| Capital Expenditures | -45K | -120K | -596K | -884K | -16K | -119K | -35K | -271K | -198K | -51K | -10K | -67K |
| Acquisitions | n/a | -15.07K | 97.6K | 3.72M | n/a | n/a | n/a | n/a | n/a | n/a | 65K | 33K |
| Purchase of Investments | -12.19M | -43.55M | -124.75M | n/a | n/a | -15.44M | -32.94M | -39.76M | -88.64M | -34.95M | -3.88M | -8.66M |
| Sales Maturities Of Investments | 65.34M | 58.62M | 27.15M | n/a | 2.5M | 33.99M | 16.88M | 59.94M | 77.51M | 22.52M | 6.55M | 16.07M |
| Other Investing Acitivies | n/a | 15.07K | -97.6K | 3.72M | n/a | n/a | n/a | n/a | 2.01M | n/a | n/a | -1K |
| Investing Cash Flow | 53.11M | 14.95M | -98.19M | 2.83M | 2.48M | 18.43M | -16.1M | 19.92M | -11.33M | -12.48M | 2.73M | 7.38M |
| Debt Repayment | n/a | n/a | n/a | -1.67M | n/a | n/a | n/a | n/a | n/a | n/a | 4.34M | -9K |
| Common Stock Repurchased | -91K | -90K | -228K | n/a | n/a | n/a | n/a | 208K | 163K | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | n/a | 103.22M | n/a | 132K | 21.52M | n/a | n/a | n/a | n/a | n/a |
| Financial Cash Flow | -91K | -90K | -228K | 189.4M | 500K | 2.98M | 23.05M | 208K | 163K | 88.52M | 4.36M | -9K |
| Net Cash Flow | 15.46M | -11.6M | -132.92M | 168.83M | -13.16M | -1.8M | -15.22M | -3.64M | -28.81M | 66.05M | n/a | n/a |
| Free Cash Flow | -37.6M | -26.58M | -35.1M | -24.29M | -15.66M | -23.35M | -22.39M | -23.96M | -17.76M | -10.04M | -6.71M | -8.3M |